{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:43Z","timestamp":1787026603068,"version":"build-2736575974"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immunosequencing has emerged as a newer clinical test for assessment of T-cell clonality in the blood and skin of cutaneous T-cell lymphoma (CTCL) patients. Utilization of immunosequencing, also known as high-throughput sequencing of the T-cell receptor (HTS-TCR), enables identification and quantification of the precise genetic signature of dominant T-cell clones. Although immunosequencing is more sensitive than commonly used methods such as polymerase chain reaction (PCR) paired with capillary electrophoresis or flow cytometry, it remains underutilized for CTCL management. Nonetheless, incorporation of HTS-TCR in clinical practice offers distinct advantages compared to other molecular analyses that may improve diagnostic evaluation, prognostication, and disease monitoring in CTCL. The objective of this comprehensive review is to provide a thorough explanation of the application of immunosequencing in the context of CTCL. We describe the significance of T-cell clonality and the methods used to detect it, including a detailed comparison between PCR paired with capillary electrophoresis and HTS-TCR. The utilization of immunosequencing in the blood and skin of CTCL patients is discussed in depth, specifically outlining how HTS-TCR can assist in diagnosing CTCL, predicting outcomes, and tracking disease progression. Finally, we address the potential applications of immunosequencing in clinical management and research as well as the novel challenges it presents.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1300061","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T23:49:00Z","timestamp":1703116140000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunosequencing applications in cutaneous T-cell lymphoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Jenna","family":"Mandel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gleason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Joffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safiyyah","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Nikbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.3390\/cancers12102921","article-title":"Epidemiology of cutaneous T-cell lymphomas: A systematic review and meta-analysis of 16,953 patients","volume":"12","author":"Dobos","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23756","article-title":"Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management","volume":"89","author":"Wilcox","year":"2014","journal-title":"Am J Hematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","first-page":"308ra158","DOI":"10.1126\/scitranslmed.aaa9122","article-title":"TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL","volume":"7","author":"Kirsch","year":"2015","journal-title":"Sci Transl Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.4.504","article-title":"Mycosis fungoides: disease evolution and prognosis of 309 dutch patients","volume":"136","author":"van Doorn","year":"2000","journal-title":"Arch Dermatol"},{"key":"B7","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Primary Cutaneous Lymphomas (Version 1.2023)2023"},{"key":"B8","article-title":"TCRgamma gene rearrangement analysis in skin samples and peripheral blood of mycosis fungoides patients","volume":"16","author":"Kandolf Sekulovic","year":"2007","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053429","article-title":"Cell biology of T cell receptor expression and regulation","volume":"36","author":"Alcover","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.0630","article-title":"Clinical end points and response criteria in mycosis fungoides and S\u00e9zary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012057","article-title":"Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC","volume":"140","author":"Olsen","year":"2022","journal-title":"Blood."},{"key":"B13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jclinpath-2017-204761","article-title":"T cell clonality assessment: past, present and future","volume":"71","author":"Mahe","year":"2018","journal-title":"J Clin Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jaad.2015.04.030","article-title":"T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides","volume":"73","author":"Sufficool","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2018-205004","article-title":"Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma","volume":"71","author":"Rea","year":"2018","journal-title":"J Clin Pathology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar5894","article-title":"High-throughput sequencing of the T cell receptor beta gene identifies aggressive early-stage mycosis fungoides","volume":"10","author":"de Masson","year":"2018","journal-title":"Sci Transl Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1243459","article-title":"Utility of T-cell immunosequencing in distinguishging mycosis fungoides progression from treatment related cutaneous adverse event","volume":"10","author":"Safiyyah Bhatti","year":"2023","journal-title":"Front Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01558","article-title":"An update on molecular biology of cutaneous T cell lymphoma","volume":"9","author":"Walia","year":"2019","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2015.09.003","article-title":"T-cell receptor profiling in cancer","volume":"9","author":"Kirsch","year":"2015","journal-title":"Mol Oncol"},{"key":"B20","article-title":"FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma _ FDA","year":"2018"},{"key":"B21","unstructured":"Understanding the ClonoSeq Assay2021"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06649.x","article-title":"T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction\/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides\/S\u00e9zary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings","volume":"153","author":"Ponti","year":"2005","journal-title":"Br J Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"214ra171","DOI":"10.1126\/scitranslmed.3007420","article-title":"Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma","volume":"5","author":"Weng","year":"2013","journal-title":"Sci Transl Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3892\/or.2020.7865","article-title":"Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous T\u2212cell lymphoma","volume":"45","author":"Gibbs","year":"2021","journal-title":"Oncol Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/DAD.0000000000001547","article-title":"Follicular eruption with folliculotropic lymphocytic infiltrates associated with iatrogenic immunosuppression: report and study of 3 cases, and review of the literature","volume":"42","author":"Avitan-Hersh","year":"2020","journal-title":"Am J Dermatopathology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14441","article-title":"Adnexotropic and granulomatous mycosis fungoides following TNF-\u03b1 inhibitor treatment","volume":"50","author":"Doughty","year":"2023","journal-title":"J Cutan Pathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.12.001","article-title":"Diagnosis of mycosis fungoides or S\u00e9zary syndrome after dupilumab use: A systematic review","volume":"88","author":"Jfri","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.12.010","article-title":"Acceleration of cutaneous T-cell lymphoma following dupilumab administration","volume":"8","author":"Russomanno","year":"2021","journal-title":"JAAD Case Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00749-1","article-title":"Development of cutaneous T-cell lymphoma following biologic treatment: A systematic review","volume":"24","author":"Schaefer","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1043254","article-title":"Advances in the understanding and treatment of Cutaneous T-cell Lymphoma","volume":"12","author":"Bakr","year":"2022","journal-title":"Front Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and s\u00e9zary syndrome: effect of specific prognostic markers on survival and development of a prognostic model","volume":"33","author":"Scarisbrick","year":"2015","journal-title":"J Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2014.134","article-title":"\u03b1\u03b2 T cell receptors as predictors of health and disease","volume":"12","author":"Attaf","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1038\/s41467-021-24343-x","article-title":"The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival","volume":"12","author":"Valpione","year":"2021","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.03.1683","article-title":"Reduced skin T-cell receptor diversity in large cell transformed mycosis fungoides","volume":"143","author":"Gleason","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-4147","article-title":"Radiotherapy eradicates Malignant T cells and is associated with improved survival in early-stage mycosis fungoides","volume":"26","author":"O'Malley","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124233","article-title":"Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma","volume":"4","author":"Vieyra-Garcia","year":"2019","journal-title":"JCI Insight"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-630335","article-title":"Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma","volume":"126","author":"Rook","year":"2015","journal-title":"Blood."},{"key":"B40","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/S0959-8049(21)00712-","article-title":"Tre-P-04 - Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial","volume":"156","author":"Musiek","year":"2021","journal-title":"Eur J Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S137106","article-title":"Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data","volume":"12","author":"Liner","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2014.944500","article-title":"Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma","volume":"7","author":"Talpur","year":"2014","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.0877","article-title":"Clinical characterization of mogamulizumab-associated rash during treatment of mycosis fungoides or s\u00e9zary syndrome","volume":"157","author":"Hirotsu","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3390\/life12122067","article-title":"Primary cutaneous B-cell lymphoma co-existing with mycosis fungoides-A case report and overview of the literature","volume":"12","author":"Chilom","year":"2022","journal-title":"Life (Basel)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70232-2","article-title":"Coexistent cutaneous T-cell lymphoma and B-cell Malignancy. French Study Group on Cutaneous Lymphomas","volume":"31","author":"Grange","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14129","article-title":"Cutaneous metastasis of primary diffuse large B-cell lymphoma of the central nervous system developing 4\u2009years after complete remission: Diagnosis confirmed by comparison of clones","volume":"49","author":"Patel","year":"2022","journal-title":"J Cutan Pathol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.030825","article-title":"Three coexisting lymphomas in one patient: genetically related or only a coincidence","volume":"59","author":"Steinhoff","year":"2006","journal-title":"J Clin Pathol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.0826","article-title":"Emergence of Malignant T-cell intraclonal CDR3 variants in mycosis fungoides","volume":"159","author":"Gleason","year":"2023","journal-title":"JAMA Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001441","article-title":"Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma","volume":"4","author":"Iyer","year":"2020","journal-title":"Blood Adv"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpor.2013.11.001","article-title":"Diagnostics in mycosis fungoides and Sezary syndrome","volume":"19","author":"Olek-Hrab","year":"2014","journal-title":"Rep Pract Oncol Radiother"},{"key":"B52","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1172\/JCI24826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejca.2018.01.076","article-title":"Blood classification and blood response criteria in mycosis fungoides and S\u00e9zary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force","volume":"93","author":"Scarisbrick","year":"2018","journal-title":"Eur J Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00830.x","article-title":"Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides","volume":"114","author":"Fraser-Andrews","year":"2000","journal-title":"J Invest Dermatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.175","article-title":"Flow cytometric detection of peripheral blood involvement by mycosis fungoides and S\u00e9zary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging","volume":"23","author":"Feng","year":"2010","journal-title":"Mod Pathol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21053","article-title":"Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardized approach","volume":"187","author":"Vermeer","year":"2022","journal-title":"Br J Dermatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.04.001","article-title":"Research techniques made simple: high-throughput sequencing of the T-cell receptor","volume":"137","author":"Matos","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010867","article-title":"The overlap of skin and blood T-cell clones in early-stage mycosis fungoides","volume":"7","author":"Joffe","year":"2023","journal-title":"Blood Adv"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.04.018","article-title":"A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome","volume":"49","author":"Benton","year":"2013","journal-title":"Eur J Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01476.x","article-title":"Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas","volume":"117","author":"Beylot-Barry","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.10.011","article-title":"T-cell monoclonality in the blood and the skin correlates with poor response to treatment in mycosis fungoides","volume":"23","author":"Geller","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B62","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1001\/jamadermatol.2022.4855","article-title":"Prognostic relevance of dominant blood T-cell clones in early mycosis fungoides","volume":"159","author":"Gleason","year":"2023","journal-title":"JAMA Dermatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.2100","article-title":"Association of a dominant T-cell clone in peripheral blood with time to systemic treatment in patients with stage IB mycosis fungoides","volume":"158","author":"Raychaudhuri","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1118357109","article-title":"High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment","volume":"108","author":"Logan","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B66","doi-asserted-by":"publisher","first-page":"134ra63","DOI":"10.1126\/scitranslmed.3003656","article-title":"High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia","volume":"4","author":"Wu","year":"2012","journal-title":"Sci Transl Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-4099","article-title":"Clonotypic diversity of the T-cell receptor corroborates the immature precursor origin of cutaneous T-cell lymphoma","volume":"25","author":"Hamrouni","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018027482","article-title":"Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing","volume":"3","author":"Iyer","year":"2019","journal-title":"Blood Adv"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1300061\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T10:43:12Z","timestamp":1703673792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1300061\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":68,"alternative-id":["10.3389\/fimmu.2023.1300061"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1300061","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]},"article-number":"1300061"}}